Cumulative mean fluorescent intensities of HLA specific antibodies predict antibody mediated rejections after kidney transplantation

It is still not fully elucidated which pretransplant donor‐specific HLA antibodies (DSA) are harmful after kidney transplantation. In particular, it needs to be clarified whether cumulative mean fluorescence intensities (MFI) against multiple HLA specificities have a predictive value for allograft function. Our retrospective single centre study analyzed preformed HLA antibodies determined by Luminex™ Single Antigen Bead (SAB) assay, including C1q addition, in relation to rejection and clinical outcome in 255 cross match negative kidney allograft recipients. Only 33 recipients (13%) of the total cohort showed early AMR during the first year posttransplant, but in patients with pre‐transplant DSA the rate was increased to 15 out of 40 (38%). Three year graft survival was significantly shorter in patients with histological signs of AMR compared with patients without AMR or with no biopsy (74%, 92%, and 97%, respectively, p < 0.0001). In patients with HLA‐DSA, a cumulative MFI value of all HLA antibodies of more than 103.000 indicated the highest risk for AMR posttransplant (p = 0.01). In conclusion, in patients with HLA‐DSA, the cumulative MFI value may help to further stratify the risk of AMR after kidney transplantation.

[1]  B. Banas,et al.  Determination of unacceptable HLA antigen mismatches in kidney transplant recipients , 2021, HLA.

[2]  S. Chadban,et al.  Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group , 2019, Transplantation.

[3]  G. Pantaleo,et al.  Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. , 2016, Human immunology.

[4]  J. Friedewald,et al.  Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  A. Konvalinka,et al.  Utility of HLA Antibody Testing in Kidney Transplantation. , 2015, Journal of the American Society of Nephrology : JASN.

[6]  A. Cabrita,et al.  Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation. , 2015, Transplant immunology.

[7]  J. Scoazec,et al.  Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. , 2015, Journal of the American Society of Nephrology : JASN.

[8]  V. Kosmoliaptsis,et al.  Questioning the added value of Luminex single antigen beads to detect C1q binding donor HLA-specific antibodies. , 2014, Transplantation.

[9]  S. Schaub,et al.  Determinants of C1q Binding in the Single Antigen Bead Assay , 2014, Transplantation.

[10]  D. Rush,et al.  Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  J. Pascual,et al.  Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? , 2013, Transplant immunology.

[12]  X. Jouven,et al.  Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.

[13]  F. Christiansen,et al.  Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. , 2013, Transplant immunology.

[14]  A. Webster,et al.  Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation , 2013, Transplantation.

[15]  Dominique Charron,et al.  Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[16]  A. Kribben,et al.  High negative predictive value of an amplified flow cytometry crossmatch before living donor kidney transplantation. , 2010, Human immunology.

[17]  D. Rush,et al.  Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure , 2010, Transplantation.

[18]  Walter K. Kremers,et al.  Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  E. Thervet,et al.  Outcome of Subclinical Antibody‐Mediated Rejection in Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  F. Heinemann.  HLA Genotyping and Antibody Characterization using the LuminexTM Multiplex Technology , 2009, Transfusion Medicine and Hemotherapy.

[21]  J. Steiger,et al.  Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads , 2009, Transplantation.

[22]  René J Duquesnoy,et al.  Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. , 2008, Current opinion in immunology.

[23]  A. Wiseman,et al.  Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  P. Terasaki,et al.  Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.

[25]  P. Terasaki,et al.  Microdroplet Assay of Human Serum Cytotoxins , 1964, Nature.

[26]  G. Einecked,et al.  Banff 07 Classification of Renal Allograft Pathology : Updates and Future Directions , 2008 .

[27]  M. Bogman,et al.  Banff classification for the histological diagnosis of renal graft rejection: what are the advantages? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.